| Human
Health & Safety |
 |
Bisphenol A and Consumer Safety
Summary
Step 1: Hazard Assessment
Step 2: Dose-Response Assessment
Step 3: Exposure Assessment
Step 4: Risk Characterization
Conclusion
References

Summary
Bisphenol A (BPA) is a key industrial chemical used
to make polycarbonate plastic, epoxy resins and other
products. Following the four-step procedure recommended
by the United States National Academy of Sciences (NRC,
1983), a safety assessment of BPA concludes that the
potential human exposure to BPA from polycarbonate plastic
and epoxy resin food contact applications is minimal
and poses no known risk to human health. This conclusion
is based on the following key points:
- BPA is not carcinogenic and does not selectively
affect reproduction or development. The No-Observed-Adverse-Effect-Level
(NOAEL) for BPA, confirmed in multiple laboratory
animal tests, is 50 mg/kg body weight/day;
- The estimated dietary intake of BPA from polycarbonate
plastic and epoxy resin food contact applications,
based on the results of multiple migration studies
with consistent results, is less than 0.000118 mg/kg
body weight/day; and
- This potential human exposure to BPA is more than
400 times lower than the maximum acceptable or "reference"
dose for BPA of 0.05 mg/kg body weight/day established
by the U.S. Environmental Protection Agency, which
is derived from the NOAEL.
An independent analysis by the European Commission's
Scientific Committee on Food (SCF), using a similar
methodology, has confirmed the safety of polycarbonate
plastic and epoxy resin food contact applications. The
SCF estimated total dietary intake of BPA from all food
contact sources to be in the range of 0.00048 to 0.0016
mg/kg body weight/day, which is below the Tolerable
Daily Intake set by the SCF of 0.01 mg/kg body weight/day.
The use of polycarbonate plastic and epoxy resins for
food contact applications has been and continues to
be recognized as safe by the U.S. Food and Drug Administration,
the European Commission's Scientific Committee on Food,
the United Kingdom Food Standards Agency, the Japanese
Ministry for Health, Labor and Welfare, and other regulatory
authorities worldwide.
The four-step safety assessment procedure is discussed
below.
Step
1: Hazard Assessment
The objective of the hazard identification step is
to qualitatively identify the health effects that may
be associated with exposure to BPA.
Carcinogenicity
The weight of scientific evidence from numerous studies,
including two long-term studies, indicates that BPA
is not carcinogenic (Haighton
et al, 2002). Among these studies are lifetime exposure
cancer bioassays conducted in rats and mice by the U.S.
National Toxicology Program (NTP,
1982). There was no convincing evidence in either
of the bioassays that BPA was carcinogenic. In addition,
BPA is without mutagenic or genotoxic activity in vivo.
These conclusions were also reached by the European
Union in their comprehensive risk assessment on BPA
(EU
RAR, 2003).
Reproductive and Developmental
Toxicity
In 1995, the Bisphenol A Toxicology Task Force of the
Society of the Plastics Industry, Inc. completed a comprehensive
review of available data on BPA. Seven laboratory animal
reproduction and development tests, including four conducted
by the U.S. National Toxicology Program, were reviewed.
These studies found no evidence that BPA selectively
affects reproduction or development. Rather, effects
on reproduction and development were observed only at
doses of BPA so high that the health of the pregnant
animal was compromised. These conclusions are consistent
with those reported in the comprehensive European Union
risk assessment on BPA (EU
RAR, 2003).
Low-Dose Hypothesis
In recent years, a hypothesis has been advanced claiming
that exposure to extremely low doses of certain substances
could cause adverse health effects in humans, including
disruption of normal hormonal functions. In science,
a hypothesis is a limited statement regarding cause
and effect that has not been confirmed through repeated
experimental tests. According to this "low-dose
hypothesis", health effects occur at doses far
below levels previously determined to be safe using
well-established toxicological procedures and principles.
The hypothesis further asserts that the dose-response
relationship for these substances is "non-monotonic",
which means that health effects may only be observed
at low doses while much higher doses result in no effects.
The claimed non-monotonic dose-response relationship
of the low-dose hypothesis is contrary to a fundamental
principle of toxicology "the dose makes
the poison."
The low-dose hypothesis is largely based on several
small-scale experimental studies that report reproductive
or developmental effects in mice or rats from low doses
of BPA. Several attempts to confirm the hypothesis by
repeating these initial experiments have shown that
the results cannot be replicated, which indicates that
the hypothesis is not valid. More importantly, definitive
large-scale experiments using accepted protocols have
also found no evidence for reproductive or developmental
effects from low doses of BPA. Consequently, a number
of independent scientific bodies, after reviewing all
available evidence, have concluded that the low-dose
hypothesis is unproven (BPA
INFO, 2002a) .
The most definitive tests of the validity of the low-dose
hypothesis for BPA are two large-scale reproductive
and developmental toxicity studies using accepted protocols.
Both of these studies clearly demonstrated the absence
of a low-dose effect of BPA.
The most comprehensive of these is a three-generation
study conducted at the Research Triangle Institute (now
RTI International) under the direction of Dr. Rochelle
Tyl (Tyl et al, 2002). In this study, Sprague-Dawley
rats were fed a diet containing BPA at levels from 0
to 7500 parts per million, yielding approximate intakes
of 0, 0.001, 0.02, 0.3, 5, 50 or 500 mg/kg body weight/day.
Exposures were continued until adulthood of the third-generation
offspring and a wide variety of relevant endpoints were
evaluated. Analysis of the data for all of the endpoints
for the parental and three offspring generations revealed
no evidence of a low-dose effect of BPA. This exceptionally
powerful study, which complied with Good Laboratory
Practice (GLP) standards, clearly demonstrated the absence
of low-dose effects for BPA.
In a similar study commissioned by the Japanese National
Institute of Health Sciences and carried out by the
Chemical Compound Safety Research Institute (Ema et
al, 2001), Crj:CD (SD) IGS rats were dosed orally by
stomach tube over two generations. The doses applied
were 0, 0.2, 2.0, 20 or 200 µg/kg body weight/day
of BPA. Analysis of the data for the parental and two
offspring generations revealed no evidence of a low-dose
effect of BPA, which is fully consistent with the results
of the Tyl study.
The lack of low-dose effects in the definitive large-scale
studies and the inability to replicate low-dose effects
reported in small-scale studies demonstrates that the
low-dose hypothesis for BPA cannot be valid. A series
of independent bodies have comprehensively reviewed
the evidence for and against low-dose effects and have
consistently reached this same conclusion.
In 2000, the U.S. National Toxicology Program (NTP)
conducted an independent scientific peer review of the
evidence for and against "low-dose endocrine disruptor"
effects (NTP,
2001). In their overall conclusion, the Bisphenol
A Subpanel stated:
"There is credible evidence that low doses of
BPA can cause effects on specific endpoints. However,
due to the inability of other credible studies in several
different laboratories to observe low dose effects of
BPA, and the consistency of these negative studies,
the Subpanel is not persuaded that a low dose effect
of BPA has been conclusively established as a general
or reproducible finding. In addition, for those studies
in which low dose effects have been observed, the mechanism(s)
is uncertain (i.e., hormone related or otherwise) and
the biological relevance is unclear." (emphasis
added)
In 2002, the European Commission completed a comprehensive
risk assessment on BPA, which includes a review of evidence
for and against low-dose effects (EU
RAR, 2003). The European Commission's Scientific
Committee on Toxicity, Ecotoxicity and the Environment
(CSTEE,
2002) independently reviewed the Risk Assessment
Report (RAR) and stated:
"[A] number of studies using non-standard protocols
have reported effects of bisphenol A administration
on development using substantially lower doses than
the studies performed according to testing guidelines.
The RAR critically describes the many weaknesses (lack
of repeatability, problems with experimental design
and statistical evaluation, poor reporting) of the low
dose studies. The CSTEE agrees with the conclusion of
the RAR that there is no convincing evidence that low
doses of bisphenol A have effects on developmental parameters
in offspring and remarks that effects observed are not
adverse."
The CSTEE further remarked, "a number of high
quality studies on the reproductive and developmental
effects of bisphenol A are already available and do
not support low-dose effects."
Also in 2002, the Japanese Ministry of Economy, Trade
and Industry released a hazard assessment of BPA (METI,
2002). In regard to the need for risk assessment or
other measures, the Ministry stated:
"Though it is necessary to collect further information
on so-called 'low dose effects' represented by BPA from
academic point of view, it seems unnecessary to take
any specific measure other than the above, considering
the view expressed by NTP Low Dose Effect Panel that
the low dose effect of BPA at present is a phenomenon
observed under considerably limited experimental conditions
and it is hardly considered to be the general phenomenon."
In addition to these assessments specifically on BPA,
other independent bodies (e.g., U.S. Environmental Protection
Agency, Japanese Ministry of Health, Labor and Welfare)
have reached similar conclusions on the validity of
the low-dose hypothesis in general (BPA
INFO, 2002a).
These weight-of-evidence assessments, the lack of low-dose
effects in definitive large-scale studies, and the inability
to replicate low-dose effects reported in small-scale
studies all support the conclusion that the low-dose
hypothesis is not valid.
Step
2: Dose-response Assessment
The objective of the dose-response assessment is to
define the relationship between exposure level (dose)
with the frequency and severity of any health effects
associated with exposure to BPA. Specific outcomes from
this step are identification of a No-Observed-Adverse-Effect-Level
(NOAEL) from animal studies, which can then be used
as the basis for calculation of a "reference dose"
or other similar values. The reference dose is defined
by the U.S. Environmental Protection Agency as an estimate
of a daily oral exposure to the human population (including
sensitive subgroups) that is likely to be without an
appreciable risk of deleterious effects during a lifetime
(EPA,
1993).
Based on the results of the lifetime exposure cancer
bioassays conducted by the U.S. National Toxicology
Program, the U.S. Environmental Protection Agency selected
50 mg/kg body weight/day as the basis for the reference
dose. The reference dose is calculated by dividing the
selected dose of 50 mg/kg body weight/day by a safety
factor of 1000, which results in a reference dose of
0.05 mg/kg body weight/day.
The results of the two multi-generation studies designed
to look for low-dose effects of BPA (Ema et al, 2001;
Tyl et al, 2002) support the use of the 50 mg/kg body
weight/day dose for calculating a reference dose. No
low-dose effects were observed in either study.
As part of a comprehensive risk assessment on BPA,
the European Union reviewed all available toxicity data,
including evidence for low-dose effects, and also concluded
that the NOAEL is 50 mg/kg body weight/day (EU
RAR, 2003).
Likewise, the Bisphenol A Toxicology Task Force estimated
the No-Observed-Adverse-Effect-Level (NOAEL) for BPA
to be 50 mg/kg body weight/day based on the dose-response
results observed in the seven reproduction and development
tests and the lifetime exposure cancer bioassays (BATTF,
1995).
Step
3: Exposure Assessment
The objective of the exposure assessment step is to estimate the level of potential human exposure to BPA. The exposure estimate can then be compared with the reference dose to determine if the potential exposure to BPA results in any risk to human health.
Potential human exposure to BPA is primarily from intake of foods and beverages that have been held in polycarbonate plastic containers or packaged in metal cans coated with an epoxy resin. For both polycarbonate plastic and epoxy resins, potential human exposure is based on measured migration data.
Polycarbonate Food and Beverage Containers
Many researchers have studied the potential for trace levels of BPA to migrate from polycarbonate into food and beverages under conditions typical for uses of polycarbonate products. These studies include ones conducted by government agencies in the US, Europe and Japan, as well as studies conducted by academic researchers and by industry.
These studies generally show that, under typical use conditions, the potential migration of BPA into food is extremely low. Migration testing under conditions that are typical of how polycarbonate products are actually used indicates that migration of BPA, when it is detected, is generally less than 5 parts per billion.
Some of the most notable examples include studies conducted by the:
- U.S. Food and Drug Administration (FDA) on baby bottles, water bottles and cut portions of baby bottles under "typical/normal use" conditions (Biles et al, 1997);
- U.K. Ministry of Agriculture, Fisheries and Food (MAFF) on baby bottles subjected to 20-50 cycles of cleaning, sterilizing and simulated use (Mountfort et al, 1997; MAFF, 1997);
- U.K. Department of Trade and Industry (DTI), Consumer Affairs Directorate on baby bottles handled under "realistic worst-case conditions of use" (Earls et al, 2000);
- Japanese National Institute of Health Sciences (NIHS) on tableware and baby bottles under conditions representative of normal consumer use (Kawamura et al, 1998); and
- Society of the Plastics Industry, Inc. (SPI) on polycarbonate discs under the most rigorous conditions recommended by FDA (Howe and Borodinsky, 1998).
These studies are not identical in design but all aimed to measure the potential
migration of BPA into foods and beverages under temperature
and time conditions considered to be typical of how polycarbonate
products are actually used. Considered together, these
studies cover a complete range of polycarbonate food contact
products and end-use conditions, which provides reassurance
that the collective results fully represent the potential
migration of BPA into foods and beverages. The results
of these studies are briefly summarized below in reference
to the type of polycarbonate product or article that was
tested. More detailed information is also available (BPA
INFO, 2002b).
Baby Bottles: Each of the studies conducted
by the government agencies included or focused entirely
on baby bottles. In most cases, new baby bottles were
studied under well-characterized laboratory conditions.
Migration was measured into infant formula, fruit juice
or a range of solvents to simulate food. In each case,
migration of BPA from new baby bottles, when detected,
was less than 5 parts per billion.
Water Bottles: In the US FDA study, water from several 5-gallon polycarbonate bottles from a bottled water supplier was analyzed with a detection limit of 0.05 parts per billion. In water that had been stored in the bottles for up to 39 weeks, BPA was found at extremely low levels ranging from 0.1 to 4.7 parts per billion.
Tableware: The Japanese NIHS study
evaluated several mugs and ricebowls along with a measuring
cup. No BPA was detected above the 0.5 part per billion
limit of detection when 3 of 5 articles were exposed
to either water (95oC for 30 minutes) or
20% ethanol (60oC for 30 minutes). Migration
of BPA was observed from the other 2 articles, but only
at levels below 5 parts per billion.
Molded Discs/Cut Pieces: In addition to evaluation of whole baby bottles, the US FDA study also tested migration from baby bottles that had been cut into pieces and immersed in food simulating solvents. For both simulants tested, the amount of BPA detected was estimated to be equivalent to migration of approximately 2 ng/ml (equal to 2 parts per billion) from a whole baby bottle.
The Society of the Plastics Industry, Inc. conducted
a study (Howe and Borodinsky, 1998) to measure migration
from molded discs that were prepared from a blend of
polycarbonate resin from three American manufacturers.
The three resins were blended and pressed into small
discs such that all surfaces were similar to that of
a finished polycarbonate product. The study was conducted
according to procedures developed by the US FDA (FDA,
1995, revised 2002) and performed using storage
time and temperature conditions recommended by the US
FDA. No BPA migration was detected in any of the samples
with a 5 part per billion limit of detection.
Using procedures recommended by the U.S. Food and Drug Administration for estimating
exposures from food-contact applications (FDA,
1995, revised 2002), and a migration value of 5
parts per billion, the estimated dietary intake of BPA
from polycarbonate food and beverage containers is less
than 0.0125 micrograms (0.0000125 milligrams) per kilogram
body weight per day (BPA
INFO, 2002b).
Epoxy Resin Can Coatings
The potential for trace levels of BPA to migrate from
epoxy resin can coatings into foods and beverages under
typical use conditions has been studies by several researchers.
The two most comprehensive studies are briefly summarized
below and more detailed information is also available
(BPA INFO,
2002c).
The Society of the Plastics Industry, Inc. (SPI) conducted
a study of BPA migration from a variety of can coatings
into food simulating solvents (Howe et al, 1998). The
test conditions used for this study were those recommended
by the U.S. Food and Drug Administration (FDA
1995, revised 2002) to exaggerate the norma l canning
processes used. No detectable migration of BPA from
the three beverage/beer can coatings tested was found
with an analytical method sensitive to 5 parts per billion.
The average level of BPA migration from the 14 cans
food cans tested was 37 parts per billion.
Based on these results and using procedures recommended
by the U.S. Food and Drug Administration for estimating
exposures from food-contact applications (FDA
1995, revised 2002), the estimated dietary intake
of BPA from canned foods and beverages lined with epoxy
coatings is less than 0.11 micrograms (0.00011 milligrams)
per kilogram body weight per day (Howe et al, 1998).
In 2001, the UK Food Standards Agency (FSA) reported
the results of a survey of BPA content in canned foods
and beverages purchased in the UK (UK
FSA, 2001; Goodson et al, 2002). The levels of BPA
found in foods and beverages are generally consistent
with the results reported by SPI (Howe et al, 1998),
which were measured in food simulating solvents. In
all but one canned beverage, BPA was not detected at
a limit of detection of 2 parts per billion, which is
below the 5 parts per billion limit of detection in
the SPI study. In most of the canned food samples, BPA,
when detected, was found at levels comparable to or
lower than the average level of 37 ppb for food cans
reported in the SPI study. For all canned foods and
beverages, the UK FSA estimated an average upper bound
BPA level of 21.7 parts per billion. Using a different
methodology that assumes higher consumption of canned
foods and beverages than the FDA methodology, the UK
FSA estimated a BPA dietary intake of 0.36 to 0.38 micrograms
per kilogram body weight per day.
Step
4: Risk Characterization
The objective of the risk characterization step is
to determine if the potential exposure to BPA, as estimated
in the exposure assessment step, will result in any
risk to human health.
Based on the results of migration studies and procedures
recommended by the U.S. Food and Drug Administration,
the estimated total dietary intake of BPA from polycarbonate
food and beverage containers and from epoxy can coatings
totals less than 0.118 micrograms (0.000118 milligrams)
per kilogram of body weight per day. The total estimated
dietary exposure to BPA from polycarbonate food and
beverage containers and from epoxy can coatings is more
than 400 times lower than the reference dose of 0.05
milligrams per kilogram body weight per day.
The Scientific Committee on Food (SCF), which is an
independent advisory committee to the European Commission
on food safety matters, has recently evaluated the safety
of BPA from all food contact sources including polycarbonate
plastic and epoxy resin coatings. The SCF set a Tolerable
Daily Intake (TDI) for BPA of 0.01 milligrams per kilogram
body weight per day after a comprehensive review of
all robust scientific data covering all aspects of toxicity.
Similar to the EPA reference dose, the TDI represents
a lifetime exposure level that is considered to be safe.
Based on the existing migration data, the total exposure
to BPA from all food contact sources was estimated to
be in the range of 0.00048 to 0.0016 milligrams per
kilogram body weight per day for adults and infants
respectively, which is below the TDI value set by the
SCF. This assessment confirms that polycarbonate plastic
and epoxy resin food contact applications are safe for
use and pose no known risk to human health (SCF,
2002).
Conclusion
The potential human exposure to BPA is more than 400
times lower than the U.S. EPA reference dose. This minimal
level of exposure to BPA poses no known risk to human
health.
The use of polycarbonate plastic and epoxy resins for
food contact applications has been and continues to
be recognized as safe by the U.S. Food and Drug Administration,
the European Commission Scientific Committee on Food,
the United Kingdom Food Standards Agency, the Japanese
Ministry for Health, Labor and Welfare, and other regulatory
authorities worldwide.
References
BATTF (Bisphenol A Toxicology Task Force), 1995, "Bisphenol
A: Summary of the Key Toxicology Studies, Estrogenicity
Data and an Evaluation of the No-Observed-Effect-Level
(NOEL)," The Society of the Plastics Industry,
Inc., Washington, D.C., February 9, 1995.
Biles, J. E., T. P. McNeal, T. H. Begley and H. C.
Hollifield, 1997, "Determination of Bisphenol-A
in Reusable Polycarbonate Food-Contact Plastics and
Migration to Food-Simulating Liquids," Journal
of Agricultural and Food Chemistry, vol. 43, pages
3541-3544.
BPA INFO (Bisphenol A Information Sheet), 2002a, "Low-Dose
Hypothesis Unproven for Bisphenol A." http://www.bisphenol-a.org/factsheets/lowdose.html
BPA INFO (Bisphenol A Information Sheet), 2002b, "Safety
of Polycarbonate Plastic." http://www.bisphenol-a.org/pdf/Polycarbonate.pdf
BPA INFO (Bisphenol A Information Sheet), 2002c, "Safety
of Epoxy Can Coatings." http://www.bisphenol-a.org/pdf/Epoxy.pdf
CSTEE (Scientific Committee on Toxicity, Ecotoxicity
and the Environment), 2002, "Opinion on the results
of the Risk Assessment of Bisphenol A Human Health Part."
http://europa.eu.int/comm/food/fs/sc/sct/out156_en.pdf
Earls, A. O., C. A. Clay, and J. H. Braybrook, 2000,
"Preliminary Investigation into the Migration of
Bisphenol A from Commercially-Available Polycarbonate
Baby Feeding Bottles," Final Report prepared by
LGC Consumer Safety Team for the Consumer Affairs Directorate,
Department of Trade and Industry, May 2000.
Ema, M., S. Fujii, M. Furukawa, M. Kiguchi, T. Ikka,
and A. Harazono, 2001, Reproductive Toxicology,
vol. 15, pages 505-523.
EC SCF (European Commission Scientific Committee on
Food), 2002, "Synoptic Document," European
Commission, Health & Consumer Protection Directorate
General, January 2002. http://europa.eu.int/comm/food/fs/sc/scf/out128_en.pdf
EPA (U.S. Environmental Protection Agency), Bisphenol
A, CASRN 80-05-7, IRIS, Integrated Risk Information
System, on-line, 1993. http://www.epa.gov/iriswebp/iris/subst/0356.htm
EU RAR, 2003. European Union Risk Assessment Report
http://ecb.jrc.it/DOCUMENTS/Existing-Chemicals/RISK_ASSESSMENT/REPORT/bisphenolareport325.pdf
FDA (U.S. Food and Drug Administration), 2002, "Preparation
of Food Contact Notifications and Food Additive Petitions
for Food Contact Substances: Chemistry Recommendations,"
Center for Food Safety and Applied Nutrition, Office
of Food Additive Safety, FDA, Washington, D.C., April
2002. http://www.cfsan.fda.gov/~dms/opa2pmnc.html
Goodson, A., W. Summerfield, and I. Cooper, 2002, "Survey
of bisphenol A and bisphenol F in canned foods,"
Food Additives and Contaminants, vol. 19, pages
796-802.
Haighton, L. A., J. J. Hlywka, J. Doull, R. Kroes,
B. S. Lynch, and I. C. Munro, 2002, "An Evaluation
of the Possible Carcinogenicity of Bisphenol A to Humans,"
Regulatory Toxicology and Pharmacology, vol.
35, pages 238-254. http://www.bisphenol-a.org/pdf/carcin_eval.pdf
Howe, S.R. and L. Borodinsky, 1998, "Potential
Exposure to Bisphenol A from Food-Contact Use of Polycarbonate
Resins," Food Additives and Contaminants,
vol. 15, pages 370-375.
Howe, S.R., L. Borodinsky and R.S. Lyon, 1998, "Potential
Exposure to Bisphenol A From Food-Contact Uses of
Epoxy Can Coatings," Journal of Coatings Technology,
vol. 70, no. 877, pages 69-74.
Kawamura, Y., Y. Koyama, Y. Takeda and T. Yamada, 1998,
"Migration of Bisphenol A from Polycarbonate Products,"
Journal of Food Hygiene, vol. 99, pages 206-212,
translated by Schreiber Translation, Rockville, MD.
http://www.bisphenol-a.org/pdf/migration.pdf
MAFF (U.K. Ministry of Agriculture, Fisheries and Food),
1997, "Investigations into the Potential Degradation
of Polycarbonate Baby Bottles During Sterilization with
Consequent Release of Bisphenol A," Central Science.
Laboratory Report FD 97/08, MAFF R&D and Surveillance
Report 253, Ministry of Agriculture, Fisheries and Food
Library, Noble House, London
METI (Japanese Ministry of Economy, Trade and Industry),
2002, "Hazard Assessment of Some Chemical Substances
Which Have Been Suspected to be Endocrine Disrupters,"
pages 328-361.
Mountfort, K.A., J. Kelly, S.M. Jickells and L. Castle,
1997, Food Additives and Contaminants, vol. 14,
pages 737-740.
NRC (U.S. National Research Council), 1983, "Risk
Assessment in the Federal Government: Managing the Process,"
National Academy Press, Washington, D.C.
NTP (U.S. National Toxicology Program), 1982, "Carcinogenesis
Bioassay of Bisphenol A (CAS No. 80-05-7) in F344 Rats
and B6C3F1 Mice (Feed Study), Technical Report Series
No. 215," NTP, Research Triangle Park, N.C. http://ntp-server.niehs.nih.gov/htdocs/LT-studies/TR215.html
NTP (U.S. National Toxicology Program), 2001, "Report
of the Endocrine Disruptors Low-Dose Peer Review,"
NTP, Research Triangle Park, N.C. http://ntp.niehs.nih.gov/ntp/htdocs/liason/LowDosePeerFinalRpt.pdf
SCF, 2002, "Opinion of the Scientific Committee
on Food on Bisphenol A", April 17. http://europa.eu.int/comm/food/fs/sc/scf/out128_en.pdf
Tyl, R. W., C. B. Myers, M. C. Marr, B. F. Thomas,
A. R. Keimowitz, D. R. Brine, M. M. Veselica, P. A.
Fail, T. Y. Chang, J. C. Seely, R. L. Joiner, J. H.
Butala, S. S. Dimond, S. Z. Cagen, R. N. Shiotsuka,
G. D. Stropp, and J. M. Waechter, 2002, "Three-Generation
Reproductive Toxicity Study of Dietary Bisphenol A in
CD Sprague-Dawley Rats," Toxicological Sciences,
vol. 68, pages 121-146.
UK FSA (United Kingdom Food Standards Agency), 2001,
"Survey of Bisphenols in Canned Foods", March
2001. http://www.food.gov.uk/science/surveillance/fsis-2001/bisphenols

|